Ethical evaluation in health technology assessment reports: An eclectic approach

International Journal of Technology Assessment in Health Care

Volumn 23, Issue 1, 2007, Pages 1-8

  Autti Rämö, Ilona ^a,b   Mäkelä, Marjukka ^b,c  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Ethical evaluation; HTA

Indexed keywords

DECISION MAKING; MATHEMATICAL MODELS; PROJECT MANAGEMENT; SOCIETIES AND INSTITUTIONS; SURGERY;

BEHAVIORAL MODELS; ETHICAL EVALUATION; HEALTH TECHNOLOGY ASSESSMENT (HTA); MORALS; STAKEHOLDERS;

HEALTH CARE;

ARTICLE; BIOMEDICAL TECHNOLOGY ASSESSMENT; EVALUATION; FINLAND; HEALTH CARE ORGANIZATION; HEALTH CARE SYSTEM; MEDICAL ETHICS; METHODOLOGY; REHABILITATION MEDICINE; SCREENING; SURGICAL INSTRUMENT; TECHNIQUE;

EVALUATION STUDIES; FINLAND; TECHNOLOGY ASSESSMENT, BIOMEDICAL; UNITED STATES;

EID: 34247483200     PISSN: 02664623     EISSN: 14716348     Source Type: Journal    
DOI: 10.1017/S0266462307051501     Document Type: Article

References (15)

1. Autti-Rämö I, Laajalahti L, Koskinen H, Sintonen H, Mäkelä M, and expert group. Screening for rare metabolic disease in newborn infants. FinOHTA report 22/2004. 2005. Available at: http://www.stakes.fi/finohta/.
2. Autti-Rämö I, Mäkelä M, Sintonen H, et al. Expanding screening for rare metabolic disease in the newborn: An analysis of costs, effect and ethical consequences for decision making in Finland. Acta Paediatr. 2005;94:1126-1136.
3. Autti-Rämö I, Koskinen H, Mäkelä M, Ritvanen A, Taipale P, and working group. Maternal ultrasound and serum screening in the detection of structural and chromosomal abnormalities. Finohta report 27/2005. 2005. Available at: http://www.stakes.fi/finohta/.
4. Beauchamp T, Childress J. Principles of biomedical ethics. New York: Oxford University Press. 2001.
5. Butler C, Darrah J. AACPDM evidence report: Effects of neurodevelopmental treatment (NDT) for cerebral Palsy. Dev Med Child Neurol. 2001;43:778-790.
6. EUR-ASSESS. Introduction to the EUR-Assess Project. Int J Technol Assess Health Care. 1997;13:133-143.
7. GRADE Working group. Grading quality of evidence and strength of recommendations. Br Med J. 2004;328:1490-1449.
8. Hailey D. Juzwishin D. Risk management for health technology assessment programs. AHFMR, HTA Initiative # 19. 2005. Available at: http://www.ahfmr.ab.ca/hta/.
9. Health Council of the Netherlands. Neonatal screening. The Hague: Health Council of the Neatherland, Publication no. 2005/11. 2005. Available at: http://www.gr.nl/.
10. Hofmann B. On value-judgements and ethics in health technology assessment. Poiesis Prax. 2005;277-295.
11. Hofmann B. Toward a procedure for integrating moral issues in health technology assessment. Int J Technol Assess Health Care. 2005;21:312-318.
12. Malmivaara A, Kuukasjärvi P, Mäkelä M, and working group. Effectiveness of invasive treatment for coronary artery disease. Overview of systematic reviews. Finohta report 25/2005. 2005. Available at: http://www.stakes.fi/finohta/.
13. Santalahti P, Aro AR, Hemminki E, Helenius H, Ryynänen M. On what grounds do women participate in prenatal screening? Prenat Diagn. 1998;18:153-165.
14. Santalahti P, Hemminki E, Aro AR, Helenius H, Ryynänen M. Participation in prenatal screening tests and intentions concerning selective termination in Finnish maternity care. Fetal Diagn Ther. 1999;14:71-79.
15. Visakorpi JK, Palo J, Renkonen O-V. The incidence of PKU in Finland. Acta Paediatr Scand. 1971;60:666-668.